Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Watching an intense hockey game could double your heart rate

Hockey fans with cardiac disease might want to watch their heart rate a little more closely this winter, a team of Canadian researchers advises.

Thumbnail

Public education of CPR, defibrillation improves survival rates for out-of-hospital cardiac arrests

Increasing educational public health initiatives across 16 North Carolina counties resulted in improved response to out-of-hospital cardiac arrest (OHCA) and better rates of survival, a study published in JAMA Cardiology reports.

Researchers quantify STEMI patients’ bleeding, ischemic risks over time

ST-segment elevation MI (STEMI) patients are at their greatest risk for ischemic and bleeding events shortly after PCI, with both risks dropping significantly over time. However, ischemic events are more common between 30 days and one year, supporting the extended use of intensified antiplatelet therapy, according to a new study in the Journal of the American College of Cardiology.

Ever wondered what it's like to work as a cardiologist in a federal prison?

The archetype of prison life is rugged: rolls of barbed wire, concrete floors, cold steel and brawls—lots of them. But what about the inmates who are limited to hospital rooms? What about those who have to be hooked up to machines to keep breathing, or have fluid drained from their lungs every day to stay alive?

Inexpensive urine test helps surgeons ID kidney injury after open heart surgery

New research out of a Fort Meyers, Florida, health center has yielded a simple and effective urine test that can detect a patient’s risk for kidney injury after open heart surgery.

ROX Medical CONTROL HTN-2 Clinical Trial; First Procedure Performed

SAN CLEMENTE, Calif., Oct. 4, 2017 — ROX Medical, Inc., a privately held medical device company pioneering an innovative interventional vascular therapy for Uncontrolled Hypertension, announced today that the first patient was treated in the CONTROL HyperTeNsion (HTN)-2 clinical study, the Company's pivotal study to evaluate the safety and effectiveness of the ROX Coupler used to create an arterio-venous anastomosis in the iliac vessels, in patients with high blood pressure.

Inhibiting signaling pathway reverses heart failure in mice

Researchers may have discovered an approach to reverse heart failure, a condition that affects nearly five million Americans and contributes to an estimated 287,000 deaths each year.

Thumbnail

Transcatheter system shows positive 1-year results in treating tricuspid regurgitation

The first patients to receive Edwards Lifesciences’ FORMA system to treat severe tricuspid regurgitation (TR) demonstrated significant clinical improvements one year after implantation, according to a study in JACC: Cardiovascular Interventions.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.